Fennec Pharmaceuticals (FENC) Operating Income (2010 - 2025)
Fennec Pharmaceuticals (FENC) posted Operating Income of -$2.6 million for Q4 2025, down 1251.32% on a QoQ basis from -$189000.0 in Q3 2025, and down 173.45% year-over-year from $3.5 million in Q4 2024.
Fennec Pharmaceuticals (FENC) Operating Income (2010 - 2025) Analysis & Trends
Fennec Pharmaceuticals' Operating Income history runs 16 years deep, the most recent figure standing at -$2.6 million for Q4 2025.
- Quarterly Operating Income fell 173.45% year-over-year to -$2.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$6.3 million (down 344.67% YoY) and the FY2025 annual result came in at -$6.3 million, down 344.63% from the prior year.
- Operating Income was -$2.6 million for Q4 2025 at Fennec Pharmaceuticals, down from -$189000.0 in the prior quarter.
- Across five years, Operating Income topped out at $13.7 million in Q1 2024 and bottomed at -$7.9 million in Q3 2022.
- A 5-year average of -$2.8 million and a median of -$4.0 million in 2021 frame the typical range for Operating Income.
- Peak annual rise in Operating Income reached 360.78% in 2024, while the deepest fall reached 411.5% in 2024.
- Fennec Pharmaceuticals' Operating Income stood at -$4.2 million in 2021, then tumbled by 45.83% to -$6.1 million in 2022, then jumped by 70.37% to -$1.8 million in 2023, then surged by 48.62% to -$934000.0 in 2024, then slumped by 173.45% to -$2.6 million in 2025.
- Business Quant data shows FENC's Operating Income at -$2.6 million in Q4 2025, -$189000.0 in Q3 2025, and -$2.7 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.76 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 249.90 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 394.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -445.22 Mn |
| 10 | Fennec Pharmaceuticals | 287.77 Mn | 250.98 Mn | 12.01 Mn | -2.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2.55 Mn |
| Sep 30, 2025 | -189,000.00 |
| Jun 30, 2025 | -2.73 Mn |
| Mar 31, 2025 | -808,000.00 |
| Dec 31, 2024 | -934,000.00 |
| Sep 30, 2024 | -5.20 Mn |
| Jun 30, 2024 | -5.04 Mn |
| Mar 31, 2024 | 13.74 Mn |
| Dec 31, 2023 | -1.82 Mn |
| Sep 30, 2023 | -1.02 Mn |
| Jun 30, 2023 | -4.67 Mn |
| Mar 31, 2023 | -5.27 Mn |
| Dec 31, 2022 | -6.14 Mn |
| Sep 30, 2022 | -7.90 Mn |
| Jun 30, 2022 | -5.01 Mn |
| Mar 31, 2022 | -3.55 Mn |
| Dec 31, 2021 | -4.21 Mn |
| Sep 30, 2021 | -4.17 Mn |
| Jun 30, 2021 | -3.92 Mn |
| Mar 31, 2021 | -4.92 Mn |